Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The designation "No pharmacological molecular target" is used in pharmacology to categorize therapeutic agents that do not exert their effects by binding to a specific biological macromolecule, such as a receptor, enzyme, or ion channel (ChEMBL, 2024). Instead, these agents typically function through physical or chemical processes that alter the physiological environment. For example, antacids neutralize gastric acid via a direct chemical reaction, while osmotic laxatives increase stool water content through physical-chemical gradients (StatPearls, 2023). This category also includes agents like activated charcoal, which acts by physically adsorbing toxins in the gastrointestinal tract, and inert contrast media used in medical imaging (PubMed, 2022). Because these substances lack a specific molecular site of action, they often exhibit broad effects and are not subject to traditional structure-activity relationship (SAR) optimization. Understanding this classification is essential for distinguishing between targeted therapies and those that modify the physiological environment through non-specific means.
Drugs associated with this label typically act through physical or chemical means rather than binding to a specific protein or nucleic acid. Examples include the chemical neutralization of acid, osmotic pull of water, or physical adsorption of molecules (DrugBank, 2024).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No pharmacological molecular target.